Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Peripheral Nerve Diseases

1-methyl-3-isobutylxanthine has been researched along with Peripheral Nerve Diseases in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chłoń-Rzepa, G1
Ślusarczyk, M1
Jankowska, A1
Gawalska, A1
Bucki, A1
Kołaczkowski, M1
Świerczek, A1
Pociecha, K1
Wyska, E1
Zygmunt, M1
Kazek, G1
Sałat, K1
Pawłowski, M1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Peripheral Nerve Diseases

ArticleYear
Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Amides; Analgesics; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phospho

2018